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An antigen capture immunoassay to detect West Nile (WN) virus antigen in infected mosquitoes and avian
tissues has been developed. With this assay purified WN virus was detected at a concentration of 32 pg/0.1 ml,
and antigen in infected suckling mouse brain and laboratory-infected mosquito pools could be detected when
the WN virus titer was 102.1 to 103.7 PFU/0.1 ml. In a blindly coded set of field-collected mosquito pools (n 
100), this assay detected WN virus antigen in 12 of 18 (66.7%) TaqMan-positive pools, whereas traditional
reverse transcriptase PCR detected 10 of 18 (55.5%) positive pools. A sample set of 73 organ homogenates from
naturally infected American crows was also examined by WN virus antigen capture immunoassay and TaqMan
for the presence of WN virus. The antigen capture assay detected antigen in 30 of 34 (88.2%) TaqMan-positive
tissues. Based upon a TaqMan-generated standard curve of infectious WN virus, the limit of detection in the
antigen capture assay for avian tissue homogenates was approximately 103 PFU/0.1 ml. The recommended WN
virus antigen capture protocol, which includes a capture assay followed by a confirmatory inhibition assay used
to retest presumptive positive samples, could distinguish between the closely related WN and St. Louis
encephalitis viruses in virus-infected mosquito pools and avian tissues. Therefore, this immunoassay demon-
strates adequate sensitivity and specificity for surveillance of WN virus activity in mosquito vectors and avian
hosts, and, in addition, it is easy to perform and relatively inexpensive compared with the TaqMan assay.
Prior to the outbreak of West Nile (WN) virus encephalitis
in New York City during the late summer of 1999, St. Louis
encephalitis virus (SLE virus) was the most important agent of
epidemic viral encephalitis in North America and the only
mosquito-borne human pathogen in the family Flaviviridae
found in this continent (27). WN virus had been previously
recognized as the cause of outbreaks of encephalitis in humans
and/or horses in Europe during the 1990s (15). It was originally
isolated from an adult female in Uganda in 1937 and has
historically circulated throughout Africa, Asia, southern Eu-
rope, the Middle East, and Australia (subtype Kunjin [KUN])
(25). The virus normally circulates in natural transmission cy-
cles involving mosquito vectors (usually Culex species) and
birds, whereas humans and horses are considered incidental or
dead-end hosts.
WN virus is a member of the family Flaviviridae, genus Fla-
vivirus, belonging to the Japanese encephalitis virus (JE virus)
serocomplex, which includes SLE virus, JE virus, Alfuy virus,
Koutango virus, KUN virus, Murray Valley encephalitis virus,
Cacipacore virus, and Yaounde virus (10). Members of the JE
serocomplex are closely related antigenically but can be differ-
entiated by plaque-reduction neutralization (PRNT) assays, by
enzyme-linked immunosorbent assay (ELISA) and indirect flu-
orescent antibody assay with virus-specific monoclonal anti-
bodies (MAbs), or by detecting WN virus-specific RNA se-
quences with reverse transcriptase PCR (RT-PCR) detection
systems (17, 28).
Since there is no proven therapy for WN encephalitis in
humans or animals, nor any human vaccine to prevent WN
virus infection, preventative public health measures, such as
the reduction of mosquito vector density, are of primary im-
portance in the control of both WN and SLE viruses. Effective
mosquito control requires rapid and sensitive surveillance of
virus activity in natural transmission cycles prior to human
infection (3, 18). Historically, the most effective means of pre-
dicting flavivirus activity has been serologic surveillance of
sentinel or wild bird populations as well as determination of
numbers of and infection rates in vector mosquitoes (3, 18).
Monitoring fatal WN virus infection in birds, especially crows,
seemed to be the most sensitive method for determining the
geographic range of virus activity in the North American out-
break (15). Even though surveillance programs are similar for
both WN and SLE viruses, the presence of both viruses in the
same geographic area requires that adequate tests be available
to differentiate these viruses.
An antigen (Ag) detection ELISA developed for SLE virus-
infected mosquito pools compared favorably in sensitivity with
the standard, traditional methods of virus isolation in cell cul-
ture and suckling mice and was a much more rapid and less
costly assay (28). We have now developed a similar Ag capture
ELISA to detect WN virus in mosquito pools and avian tissue
homogenates that compares favorably in sensitivity to both
virus isolation in cell culture and traditional RT-PCR. In com-
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bination, these two Ag detection assays can differentiate be-
tween WN and SLE viruses in both laboratory-infected and
naturally infected specimens. Even though the Ag capture
ELISA is generally less sensitive than the TaqMan assay for
WN virus, it is a reasonable and less expensive alternative for
those laboratories not equipped for quantitative RT-PCR
analysis. Moreover, the use of well-characterized MAbs in
these ELISAs readily permits standardization among labora-
tories.
MATERIALS AND METHODS
Viruses. All virus strains were obtained from the reference collection at the
Division of Vector-Borne Infectious Diseases (DVBID), Centers for Disease
Control and Prevention, Ft. Collins, Colo. WN virus strain NY99 and SLE virus
strain MSI-7 were grown in Vero and SW-13 cell cultures, respectively, and
purified from clarified cell culture supernatants by polyethylene glycol precipi-
tation followed by rate-zonal and isopycnic centrifugation on glycerol-tartrate
gradients as previously described (26). Protein concentrations of purified virions
were determined by the Bio-Rad protein assay (Bio-Rad, Hercules, Calif.). Stock
viral seeds were prepared from infected suckling mouse brain (SMB) or infected
C6/36 cell culture supernatant and included the following virus strains: WN (Eg
101), SLE (TBH-28), yellow fever (17D), Ilheus (original), Rio Bravo (M64),
dengue 1 (Hawaii), dengue 2 (New Guinea C), dengue 3 (H87), dengue 4
(H241), eastern equine encephalitis (EEE) (NJ60) and Venezuelan equine en-
cephalomyelitis (TC-83).
Antibodies. The isolation and characterization of the murine MAbs 3.91D,
6B6C-1, 4A4C-4, and 4G2 have been described previously (1, 6, 23, 24). WN
virus capture MAb 3.91D, an immunoglobulin G3 (IgG3) subclass antibody, is
specific for the closely related WN and KUN viruses, and SLE virus capture
MAb 4A4C-4, an IgG2A subclass antibody, is SLE virus type specific. The
detecting MAb 6B6C-1 (subclass IgG2A) is flavivirus group reactive and was
commercially conjugated to horseradish peroxidase (HRP) (Jackson Immunore-
search Laboratories, West Grove, Pa.). MAb 4G2, a flavivirus group-reactive,
subclass IgG2A antibody, was used as a capture antibody for heterologous
flaviviruses. High-titer antiviral antibody preparations in the form of murine
hyperimmune ascitic fluids (HIAF) for WN, SLE, and EEE viruses were used in
the Ag capture inhibition tests. These reagents were obtained from the DVBID.
Mosquito inoculation and processing. To evaluate the sensitivity of the WN
virus Ag capture assay for mosquito pool specimens, Aedes albopictus (Keyport
strain) mosquitoes were inoculated intrathoracically with WN virus (NY99-6480)
and Aedes aegypti (DQ strain) mosquitoes were inoculated intrathoracically with
SLE virus (TBH-28). The infected mosquitoes were held at least 6 days at 27°C.
Uninfected A. aegypti mosquitoes were used for negative controls.
WN and SLE virus laboratory-infected mosquitoes were processed either as
single specimens or in pools of 50 (1 virus positive and 49 virus negatives).
Field-collected mosquitoes, identified as Culex spp., Culex pipiens, or Culex restu-
ans, were placed in pools of 3 to 51 individuals. Single mosquitoes or pools were
placed in 4-ml cryogenic, polypropylene, round-bottom vials (Corning Inc., Corn-
ing, N.Y.) with 2 ml of BA-1 diluent (1 medium 199 with Hanks’ balanced salt
solution, 0.05 M Tris buffer [pH 7.6], 1% bovine serum albumin, 0.35 g of sodium
bicarbonate per liter, 100 g of streptomycin per ml, 100 U of penicillin G per
ml, 1 g of amphotericin B [Fungizone] per ml). Mosquito preparations were
ground with a MOSAVEX device for 20 to 30 min by placing four 4.5-mm-
diameter, copper-clad steel beads (BB-caliber airgun shot) into the tube with the
mosquitoes and diluent (5). The mosquito homogenate and steel beads were
centrifuged at 3,700 rpm for 20 min to create a pellet of solids. Aliquots of the
supernatant were used for plaque assay, Ag capture ELISA, and RNA extraction
for TaqMan and RT-PCR (2, 17).
Avian organ homogenates. Twenty American crow (Corvus brachyrhynchos)
carcasses, collected in New Jersey in the fall of 1999, were processed to remove
samples of various organs: brain, liver, spleen, kidney, heart, and lung (21).
Approximately 0.5 cm3 of each tissue was placed in 1.8 ml of BA-1 diluent,
homogenized in glass Ten Broeck tissue grinders, and then clarified by centri-
fugation. The supernatants were used for plaque assay, Ag capture ELISA, and
RNA extraction for TaqMan (2, 17).
Antigen capture ELISA. The Ag capture immunoassay procedure is essentially
that described by Tsai et al. (28). Four WN virus- or WN and KUN virus-specific
MAbs were evaluated for their ability to serve as an adequate Ag capture reagent
(1, 7, 8, 24) (data not shown). We identified 3.91D, a WN- and KUN-specific
MAb, as a satisfactory capture antibody because it was able to capture WN viral
Ag with a sensitivity similar to that shown by MAb 4A4C-4 for SLE viral Ag, and
it also showed good reactivity with a wide range of WN and KUN virus isolates
(1, 24, 29). One hundred microliters of an optimum dilution (1:2,000) of 3.91D
ascites, determined by a boxed titration with WN virus-infected SMB, was used
to coat Immulon 2 microtiter plates (Dynex Technologies, Chantilly, Va.). Plates
were washed following each incubation step with phosphate-buffered saline
(PBS), pH 7.2, with 0.05% Tween 20 (PBS-T) and blocked prior to sample
addition with 300 l of blocking buffer (1% nonfat dry milk, 0.1% Tween 20 in
PBS). One hundred-microliter volumes of homogenized mosquito pool, virus-
infected SMB, or avian tissue supernatant, including uninfected controls, were
added to duplicate wells and incubated overnight at 4°C for the greatest sensi-
tivity or, alternatively, at 37°C for 3 h. To reduce background or increase test
sensitivity, mosquito pool supernatants were treated with a final concentration of
0.5% Tween 20 in PBS for 15 to 30 min at room temperature before being added
to the blocked plate. Detector MAb 6B6C-1-HRP (100 l of a 1:10,000 dilution
in blocking buffer) was added, the mixture was incubated for 1 h at 37°C, and this
was followed by the addition of substrate, 3,3,5,5-tetramethylbenzidine (TMB-
ELISA; Gibco BRL, Gaithersburg, Md.). The plates were incubated for 15 min
in the dark, and color development was stopped by the addition of 50 l of 1 N
H2SO4. The absorbance was measured in an ELx808 microplate reader at 450
nm (BioTek Instruments, Winooski, Vt.).
The SLE virus Ag capture test was run in a similar manner, as previously
described (28), using a 1:4,000 dilution of MAb 4A4C-4 ascites as capture
antibody and positive controls consisting of SLE virus-infected SMB seed virus
stocks or inactivated Ag. For either capture assay, the mean absorbance was
calculated for each sample tested in duplicate, as well as for the uninfected
controls. Test samples were scored as presumptive positives if their mean absor-
bance was greater than twice the mean absorbance of the normal controls. This
value can be expressed as an absorbance ratio, (mean A450 of test sample)/(mean
A450 of normal control).
To examine the specificity of the WN virus Ag capture ELISA, parallel tests
were run comparing the reactivity of WN- and KUN-specific MAb 3.91D and
group-reactive MAb 4G2 as capture antibodies. Plates were coated with either
3.91D (1:2,000) or 4G2 (1:4,000) diluted in coating buffer, pH 9.6, and incubated
overnight at 4°C. The test was run as described for the Ag capture assay with a
panel of flavivirus-infected SMB or C6/36 infectious seed pools as Ags in the test.
MAb 6B6C-1-HRP was used to detect captured Ag.
Antigen capture inhibition assay. Mosquito pools or avian tissue homogenates
that had positive reactions in the WN virus Ag capture ELISA were confirmed
in an inhibition assay, performed as described by Tsai et al. (28). Twenty micro-
liters of a 1:20 dilution of WN HIAF was mixed with 100 l of each sample that
was positive for WN viral Ag, and incubated for 1 h at 37°C. A control antibody
(EEE HIAF) was also mixed with each sample in a separate reaction mixture.
These mixtures were retested in the capture ELISA by adding 100 l of each
mixture to a capture antibody-coated, blocked plate and completing the assay as
usual. Test samples were considered to be confirmed as positive for WN virus if
the calculated inhibition was greater than 50%, i.e., if [1.00  (A450 of sample
WN HIAF)/(A450 of sample  EEE HIAF)]  100 was 50.
TaqMan assay and traditional RT-PCR. The method for isolating viral RNA
from virus seeds, mosquito pools, and homogenized avian tissues was essentially
that described by Lanciotti et al. (17). The QIAamp viral RNA kit (QIAGEN,
Valencia, Calif.) was used to extract RNA from an aliquot of the same super-
natant used for Vero cell plaque assay. RNA was always eluted from the QIA-
GEN columns in a volume of elution buffer equal to the volume of the extracted
sample and was stored at 70°C. WN virus (NY99 strain, GenBank accession
number AF196835), TaqMan, and RT-PCR primers used with all laboratory-
infected or naturally infected samples were those previously described: WN-
ENV-forward, reverse, and probe primers for TaqMan, and WN233 and
WN640c primers for RT-PCR (17). SLE virus TaqMan primers and probe were
designed using the envelope glycoprotein sequence information from several
SLE virus strains stored at DVBID (16).
The standard RT-PCR assay was performed with the TITAN One-Tube RT-
PCR kit (Roche Molecular Biochemicals, Indianapolis, Ind.) using 5 l of RNA
and 50 pmol of each primer in a 50-l reaction mixture and was analyzed on a
3% NuSieve 3:1 agarose gel (FMC Bioproducts, Rockland, Maine) (17). The
TaqMan assay, with 5 l of RNA, 50 pmol of each primer, and 10 pmol of a
probe labeled with the reporter dye 6-carboxyfluorescein and the quencher dye
6-carboxytetramethylrhodamine, was performed and analyzed as previously de-
scribed (17). Quantitation of WN or SLE virus in laboratory-infected mosquito
pools and WN virus in avian tissue homogenates was carried out by generating
a standard curve with plaque assay-titrated virus seeds with the PE 7700 Se-
quence Detection System Software (PE Applied Biosystems, Foster City, Calif.).
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RESULTS
Sensitivity evaluations. The sensitivity of this Ag capture
assay was evaluated by determining the minimum amount of
virus or viral Ag that could be detected from three sources of
virus: purified virus, virus-infected SMB preparations, and lab-
oratory-infected mosquito pools. Because the SLE virus Ag
capture test required an overnight incubation of Ag and use of
TMB as the HRP substrate to achieve the greatest sensitivity,
both the overnight incubation step and the TMB substrate
were used for the WN virus Ag capture ELISA (28).
The ranges of viral Ag detected for WN or SLE purified
virus (based on amount of viral protein) and virus-infected
SMB (based on infectious titer) were very comparable: 21.5 to
43 pg/0.1 ml and 102.25 to 102.9 PFU/0.1 ml for WN virus, and
62 pg/0.1 ml and 102.5 to 103.0 PFU/0.1 ml for SLE virus.
Detection of Ag in laboratory-infected mosquito pools,
whether the pool consisted of a single infected mosquito alone
or mixed with 49 uninfected mosquitoes, was slightly more
sensitive for the SLE virus Ag capture test (102.3 to 102.8
PFU/0.1 ml), regardless of Tween 20 treatment. The WN virus
Ag capture test detected 103.1 to 103.95 PFU of WN virus/0.1 ml
in untreated mosquito pools and 102.8 to 103.75 PFU of virus/
0.1 ml in Tween 20-treated mosquito pools. The number of
mosquitoes in the pool, 1 or 50, did not affect the sensitivity of
WN virus Ag detection. Incubation of the virus-infected SMB
or mosquito pool sample for 15 to 30 min at room temperature
with a final concentration of 0.5% Tween 20 was done in an
attempt to increase test sensitivity by disrupting membranes
containing the envelope glycoprotein, a procedure that did
increase the sensitivity of an Ag capture assay for EEE virus
(4). Treatment with Tween 20 did result in some reduction in
the test background, but very little or no increase in sensitivity
was observed for most samples; therefore, the additional time
and effort for detergent treatment did not seem warranted.
The results with all WN virus laboratory-infected mosquito
pools were confirmed by the WN virus Ag capture inhibition
test by using WN HIAF as the positive polyclonal antibody
inhibitor; SLE HIAF as a cross-reactive, positive antibody in-
hibitor; and EEE HIAF as a normal control antibody (nonin-
hibitor). All 10 WN virus-infected pools showed high levels of
inhibition with WN HIAF (mean of 85.9% inhibition) but
lower levels of inhibition with SLE HIAF (mean of 63.6%
inhibition), indicating that it is important to use a homologous
HIAF inhibitor for the most sensitive test.
The ability to detect WN virus Ag in laboratory-infected
mosquitoes depended upon the length of the extrinsic incuba-
tion period following virus inoculation. The WN virus Ag cap-
ture ELISA could detect viral Ag in pools composed of 1
infected plus 49 uninfected mosquitoes at 48 h postinoculation
(hpi) if the homogenized pool was treated with 0.5% Tween 20
or at 72 hpi without detergent treatment (data not shown). The
infectious titer present in the mosquito pools as measured by
plaque assay increased from102 PFU/0.1 ml at 24 hpi to 103.5
or 105.2 PFU/0.1 ml at 48 and 72 hpi, respectively.
Specificity determinations. We tested the ability of 3.91D to
capture heterologous virus from high-titer virus-infected SMB
preparations. Although these high-titer, heterologous Ags
were captured by 3.91D, absorbance ratios were 6.2- to 62.5-
fold lower than those obtained with the homologous WN virus
(Table 1). Conversely, all flaviviruses tested (except dengue 1
virus) had similar absorbance ratios when the flavivirus group-
reactive MAb 4G2 was used as the capture antibody, indicating
that the inability of 3.91D to capture heterologous flaviviruses
was a result of its specificity and not due to insufficient Ag. The
reactivity of all dengue 1 virus preparations examined was low
with 4G2, most likely reflecting the low titer of the prepara-
tions. Not unexpectedly, SLE virus had the highest level of
cross-reactivity with the 3.91D capture antibody; however, the
absorbance ratio on 3.91D for SLE virus was significantly lower
(6.2-fold) than the absorbance ratio for WN virus.
Results of testing 10 WN virus and 10 SLE virus laboratory-
infected mosquito pools in both the WN and SLE virus Ag
capture assays revealed excellent specificity (data not shown).
Five WN virus laboratory-infected mosquito pools composed
of a single infected mosquito (P1) or five pools of 1 infected
mosquito plus 49 uninfected mosquitoes (P50) had average
WN virus Ag capture ELISA endpoints within twofold of one
another (corresponding to infectious titers of 102.8 to 103.1
PFU/0.1 ml), but none of these WN virus-infected pools were
detected in the SLE virus Ag capture assay. The same speci-
ficity was shown for the SLE virus laboratory-infected mos-
quito pools, since none of the pools cross-reacted in the WN
virus Ag capture ELISA. The average SLE virus Ag capture
ELISA endpoints for the P1 and P50 mosquito pools were
within fourfold of one another (corresponding to infectious
titers of 102.2 to 102.8 PFU/0.1 ml).
Validation testing with field-collected specimens. A blindly
coded set of 100 naturally infected mosquito pools (collected in
New Jersey during 2000) were tested in the WN virus Ag
capture ELISA; presumptive positive pools were retested in
the inhibition ELISA. The pools found to be positive for WN
virus contained from 3 to 51 mosquitoes identified as Culex
spp., C. pipiens, or C. restuans. The complete set of mosquito
pools was first evaluated by virus isolation in a plaque assay
and by TaqMan for the presence of viral RNA. In addition, all
isolation-positive samples were also tested by traditional RT-
PCR. Of the 100 pools, 20 were positive for virus isolation, but
only 18 isolates could be confirmed as WN virus. The compar-
ative results for the 18 confirmed WN virus-positive pools are
shown in Fig. 1. The WN virus Ag capture ELISA detected Ag
TABLE 1. Specificity of the WN virus Ag capture ELISA with
other flaviviruses
Virusb
Absorbance ratioa of viral Ags on capture MAb
WN virus-specific
MAb 3.91D
Flavivirus group-reactive
MAb 4G2
WN 81.3 69.4
SLE 13.1 71.5
Yellow fever 1.3 65.9
Ilheus 6.6 62.3
Rio Bravo 10.9 65.6
Dengue 1 1.8 30.0
Dengue 2 6.0 71.6
Dengue 3 1.4 52.8
Dengue 4 6.0 57.4
VEEc 1.0 0.95
a Absorbance ratio, A450 of test sample/A450 of normal control sample.
b Virus seed preparation in SMB or tissue culture fluid.
c VEE, Venezuelan equine encephalomyelitis virus, an alphavirus control.
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in 12 of the 18 positive pools (66.7%). The Ag capture test was
not as sensitive as TaqMan, which detected 100% of the pos-
itive pools, but it showed good specificity in that all pools found
to be negative by plaque assay and TaqMan were also negative
by WN virus Ag capture; i.e., no false positives were found. For
this set of samples, the Ag capture assay showed slightly
greater sensitivity than traditional RT-PCR, which detected 10
of 18 TaqMan-positive pools (55.5%), whereas 2 of 18 pools
(11.1%) gave equivocal results. All but one of the RT-PCR-
positive pools were also positive by Ag capture ELISA. The
WN virus Ag capture inhibition test was performed on the 12
mosquito pools scored as presumptive positives in the Ag cap-
ture assay; all 12 pools were confirmed as positive, with WN
HIAF inhibition values ranging from 78.9 to 96.6% (data not
shown).
The plaque assay data for the WN virus-positive pools that
were detected by Ag capture revealed that the number of PFU
per 0.1 ml of suspension varied from 1 to 46 countable plaques
up to an undeterminable number of plaques that covered the
entire cell sheet (data not shown). Therefore, for some pools,
a very low infectious virus titer was detectable by Ag capture.
On the other hand, the average number of PFU per 0.1 ml for
isolation-positive, Ag-capture-negative pools was 15 (range, 3
to 32 PFU/0.1 ml). Comparison of the TaqMan and WN virus
Ag capture data for WN virus-positive pools showed that sam-
ples with a TaqMan threshold cycle (Ct) number of 29 but
30 may or may not be detected in the Ag capture test.
However, all samples with TaqMan Ct values of 29 were
positive by Ag capture, while all samples with Ct values of 30
were negative in the Ag capture ELISA (Fig. 1). TaqMan Ct
values are inversely related to the amount of viral RNA in the
sample, i.e., samples with high amounts of viral RNA are
detected after fewer cycles and have a relatively lower Ct value.
The principal use of the SLE virus Ag capture assay is as a
surveillance tool to monitor virus activity in the mosquito vec-
tor. However, because of the importance of the dead-bird
monitoring system as a sensitive surveillance tool in the North
American outbreak of WN virus, evaluation of the WN virus
Ag capture assay for virus detection in avian tissue was under-
taken (15). A coded set of 73 organ homogenates from 20
naturally infected American crows (C. brachyrhynchos), col-
lected during the fall of 1999 as part of the dead-bird survey in
New Jersey, was tested by plaque assay, TaqMan, and WN
virus Ag capture ELISA and inhibition ELISA. In this sample
set fewer tissues were positive by plaque assay (26 of 73
[35.6%]) than by TaqMan (34 of 73 [46.6%]) for WN virus.
This result is not surprising because the tissues were obtained
from carcasses, and recovery of infectious virus could have
been dependent upon the amount of decomposition that had
occurred as well as on the ability to isolate virus from different
organs. The eight specimens that tested positive for virus by
TaqMan and negative for virus by isolation came from five
different birds, and other tissues (such as brain) from four of
FIG. 1. Comparison of Ag capture ELISA, TaqMan, and traditional RT-PCR used to test pools of naturally infected mosquitoes. TaqMan Ct
values represent the threshold cycle number at which fluorescence increases above a fixed threshold value. Symbols: Œ, pools positive by TaqMan,
Ag capture ELISA, and RT-PCR; , pools positive by TaqMan and Ag capture ELISA but equivocal or negative by RT-PCR; , pool positive
by TaqMan and RT-PCR, but negative by Ag capture ELISA; F, pools positive by TaqMan only. ELISA plates were read at 450 nm; all symbols
below the dotted line represent negative results by Ag capture ELISA.
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these five birds yielded positive plaque assay results (data not
shown).
Thirty-one of 34 TaqMan-positive avian samples were de-
termined to be presumptive positives by the WN virus Ag
capture ELISA (Fig. 2A). The three samples that were virus
negative by ELISA are located below the horizontal dotted line
in Fig. 2A. The one sample that was virus negative by TaqMan
and a presumptive positive by Ag capture could not be con-
firmed as positive by the WN virus Ag capture inhibition test.
One other sample that was virus positive by TaqMan and a
presumptive positive by Ag capture was also not confirmed by
the inhibition test. All other samples identified as virus positive
by the WN virus Ag capture assay were confirmed by the
inhibition test, with values ranging from 67 to 96.7% inhibition
(data not shown). Thus, for this sample set there was very good
agreement between the number of WN virus-positive samples
detected by WN virus Ag capture ELISA (41.1% positive) and
the TaqMan assay (46.6% positive).
As was observed for the mosquito pool sample set, a corre-
lation was found between TaqMan Ct values and results of the
WN virus Ag capture ELISA for the avian samples. In this
case, samples with Ct values of 29 tested positive by Ag
capture, whereas those with Ct values of 29 tested negative
by Ag capture (Fig. 2A). The inset in Fig. 2A shows the linear
relationship between Ct values and infectious virus titer, based
upon a set of RNA standards from a WN virus seed with an
established titer. It can be determined from this inset graph
that a Ct value of 29 corresponds to about 102 PFU/5 l
(volume used for TaqMan) or 103.3 PFU/0.1 ml (volume used
for Ag capture). Therefore, the latter value would be the cal-
culated limit of detection, based on infectious virus, for the
WN virus Ag capture ELISA. The actual numbers of PFU per
0.1 ml observed by plaque assay for the Ag capture-positive
avian homogenates ranged from zero to too numerous to count
(data not shown).
Although it was previously established that an overnight
incubation with the test sample resulted in the most sensitive
Ag detection for mosquito pool samples, results of a 37°C, 3-h
incubation and an overnight incubation were compared for 22
WN virus Ag-positive avian organ homogenates. Twenty-one
of the 22 samples were scored as positive in the short-incuba-
tion test, but 19 of these 22 samples had lower A450 readings
than the same samples evaluated after overnight incubation.
However, these results indicate that a short-incubation test
might be adequate, especially for samples expected to have
high concentrations of viral Ag, which is the case for a number
of avian species infected with WN virus.
All 30 avian organ homogenates confirmed as positive by the
WN virus Ag capture and inhibition ELISAs were also tested
in the SLE virus Ag capture assay. Although there is no rec-
ognized surveillance value in testing wild bird carcasses for
SLE virus, this heterologous assay was performed strictly to
assess the degree of cross-reactivity that could occur with field
specimens containing high concentrations of virus Ag. Sample
absorbance ratios calculated from the WN and SLE virus Ag
capture tests were compared in a scatter plot (Fig. 2B). Seven
of the 30 samples confirmed as WN virus positive were cross-
reactive in the SLE virus Ag capture test, since they had ab-
sorbance ratios above the threshold value of 2.0 (absorbance
ratio range, 2.3 to 19.8). However, none of the seven samples
were confirmed as positive by the SLE virus Ag capture inhi-
bition test.
DISCUSSION
The focus of surveillance for epidemic vector-borne diseases
is to measure viral activity in the vector and vertebrate host
populations in order to assess the disease risk for humans and
animals and to assist in targeting and evaluating vector control
efforts (13, 29). For SLE virus, it is generally accepted that
there are threshold levels of infection rates in vector mosqui-
toes and birds that must be exceeded before there is a risk of
transmission to humans. The SLE virus threshold infection
rate in mosquitoes for such an epidemic threat is based on
virus isolation and varies from 5 to 10 per 1,000 Culex tarsalis
mosquitoes (28). This general principle undoubtedly applies to
WN virus, although the relationship between infectious virus
titers in mosquitoes and the ability to routinely transmit virus
has not been experimentally established, nor has any specific
infection rate been related to epidemic transmission.
For approximately 2 decades, there has been wide accep-
tance of enzyme immunoassays which have proven to be both
sensitive and specific as tools for rapid virus diagnosis (20, 30).
These characteristics as well as the capability to rapidly process
large numbers of samples are valuable in an assay used for
surveillance purposes. Such assays should enhance surveillance
effectiveness both by increasing the number of laboratories
capable of performing tests and by lengthening the period in
which vector control can be undertaken (4, 12, 28, 29, 31).
Within the last 10 years, rapid, sensitive and specific nucleic
acid-based assays employing RT-PCR or TaqMan have been
developed for several RNA viruses, including WN virus (17,
22). In connection with developing an ELISA-based Ag detec-
tion assay for WN virus, we have also compared the perfor-
mance of this test with TaqMan and traditional RT-PCR using
two blindly coded sets of field-collected specimens.
The WN virus Ag capture ELISA offers the advantage of a
simple, rapid in vitro procedure that is less expensive to run
than TaqMan, is less sensitive to contamination problems than
nucleic acid-based assays, has an internal confirmatory test,
and does not require the extensive support facilities needed for
conventional methods of virus isolation (cell culture and ani-
mal facilities). Another important aspect of this assay is the
stability of the viral protein, which does not require a cold
chain to maintain reactivity; moreover, detection of Ag may be
improved after procedures such as sonication or freeze-thaw
cycles (29). The capture assay is adaptable to a dipstick or
wicking assay that may be easier for use in the field or for
testing a small number of samples. The WN virus Ag capture
test was designed as a MAb-based assay for a number of
reasons: (i) to make it compatible with the previously devel-
oped SLE virus Ag capture test so that these tests could be run
in tandem; (ii) to provide a theoretically infinite antibody sup-
ply; (iii) to utilize capture and detector antibodies with defined,
stable antigenic specificities; and (iv) to reduce the need for
routine test restandardization. Because the SLE and WN virus
Ag capture tests are based on a similar protocol, the flavivirus
group-reactive detector, MAb 6B6C-1-HRP, can be used in
both tests, thus limiting the number of enzyme conjugates
required.
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FIG. 2. Sensitivity and specificity of the Ag capture ELISA used to test organ homogenates of naturally infected American crows. (A) Analysis of
samples positive (F) and negative () for virus isolation by Ag capture ELISA and TaqMan. A  with a superimposed white represents a sample which
could not be confirmed as positive by the Ag capture inhibition test. A total of 35 WN virus-positive samples from 73 homogenates tested are shown.
Symbols below the horizontal dotted line indicate samples negative by Ag-Cap ELISA; symbols to the right of the arrow (TaqMan Ct  37) indicate
samples below the threshold Ct for TaqMan (Ct is the threshold cycle number at which fluorescence increases above a fixed threshold value). The insert
shows the linear relationship between virus titer (log10 PFU/0.005 ml) and Ct value for a set of RNA standards from a previously titrated WN virus seed
included in the TaqMan assay. (B) Cross-reactivity of avian organ homogenates tested in Ag capture assays for both WN and SLE viral Ags. The
absorbance ratio is calculated as A450 of test sample/A450 of normal control sample; ratios of2.0 are considered significant. The dotted and dashed lines
show the 2.0 absorbance ratio thresholds for the SLE and WN virus Ag capture ELISAs, respectively.
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Initial experiments that used purified virus, virus-infected
SMB, and laboratory-infected mosquito pools revealed that
the WN virus Ag capture test was as sensitive as the corre-
sponding test for SLE virus. A MAb-based Ag capture assay
for EEE virus was similar in sensitivity to the WN virus assay
for virus-infected SMB but detected a minimum of only ap-
proximately 105 PFU/0.1 ml from virus-infected mosquito
pools (4). The limit of detection for yellow fever virus by Ag
capture ranged from 103.3 to 103.8 PFU/0.1 ml (19). Sensitivity
comparisons to previously published Ag capture ELISAs for
other arboviruses are difficult to make, because these studies
used 50% tissue culture infective dose units as endpoints to
assess infectivity levels rather than plaque assays (9, 11, 13, 14).
The detection of WN virus in naturally infected mosquitoes
was essentially equivalent by plaque assay and TaqMan; the Ag
capture test detected 66.7% of the pools that were positive by
both TaqMan and isolation. This is similar to the results of Tsai
et al. (28) for SLE virus-infected mosquitoes. Those investiga-
tors stated that this limited level of sensitivity may not prevent
the capture assay from detecting mosquitoes that are capable
of transmitting virus, because such mosquitoes generally have
a disseminated, high-titer virus infection. If one of the main
objectives of surveillance efforts is identifying vectors capable
of transmitting virus, then the WN virus Ag capture test would
be an effective primary or confirmatory assay. Ag capture
and/or traditional RT-PCR would be viable alternatives for
laboratories without TaqMan or tissue culture capabilities.
A high proportion (30 of 34) of the avian homogenates that
were positive by TaqMan were also positive for WN virus by
Ag capture ELISA. The high correlation between these two
assays was most likely due to the high viral titers (or high
concentrations of Ag) in many of these samples, since 25 of 34
samples positive by TaqMan had titers in excess of 104 PFU/0.1
ml (which corresponds to titers of at least 102.7 PFU/5 l and
Ct values of 25.4 or less [Fig. 2A]). However, 8 of 30 Ag
capture-positive samples had very low or no PFU counts in
Vero cell culture (0 to 4.5 PFU/0.1 ml), yet these samples were
still detected by ELISA and had TaqMan-based titers in excess
of 103 PFU/0.1 ml. These results are most likely due to detec-
tion of noninfectious nucleic acid by TaqMan and noninfec-
tious Ag by the ELISA. It is not unlikely to expect a discrep-
ancy between the amount of infectious virus compared with the
amount of Ag due to conditions of collection, storage, trans-
port, and number of freeze-thaw cycles to which the specimens
may be subjected. Moreover, as discussed by Lanciotti et al.
(17), the WN virus TaqMan assay amplifies small DNA frag-
ments (typically 100 bp) and it is possible to generate the
fluorescent signal without synthesis of full-length DNA prod-
ucts, both of which are factors that lead to increased assay
sensitivity.
Despite the lack of absolute specificity (Table 1) (28), the WN
and SLE virus Ag capture tests, in conjunction with their corre-
sponding inhibition assays, showed sufficient specificity with the
field-collected specimens tested, since none of the 30 avian tissues
confirmed as WN virus positive by Ag capture had confirmed
heterologous reactions in the SLE virus Ag capture assay. In
addition, the two assays were able to differentiate WN virus lab-
oratory-infected and SLE virus laboratory-infected mosquito
pools. The appearance of WN virus in the United States has
resulted in an important change in arbovirus disease ecology and
epidemiology, both locally and, ultimately, throughout the West-
ern Hemisphere. The great majority of states in the United States
have had documented human cases of SLE within the past 4
decades, although more recent cases have been associated with
the southern states (23a). Probable expansion of WN virus into
areas of more-recent SLE virus activity could lead to cocirculation
of these flaviviruses, which could complicate laboratory virus
identification tests. Considering the continuing spread of WN
virus, it is notable that the specificity of these MAb-based, Ag
capture assays appears to be adequate to meet the ever-increasing
surveillance needs.
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